Genome-wide Meta-analysis Finds the ACSL5-ZDHHC6 Locus Is Associated with ALS and Links Weight Loss to the Disease Genetics
Alfredo Iacoangeli,Tian Lin,Ahmad Al Khleifat,Ashley R Jones,Sarah Opie-Martin,Jonathan R I Coleman,Aleksey Shatunov,William Sproviero,Kelly L Williams,Fleur Garton,Restuadi Restuadi,Anjali K Henders,Karen A Mather,Merilee Needham,Susan Mathers,Garth A Nicholson,Dominic B Rowe,Robert Henderson,Pamela A McCombe,Roger Pamphlett,Ian P Blair,David Schultz,Perminder S Sachdev,Stephen J Newhouse,Petroula Proitsi,Isabella Fogh,Shyuan T Ngo,Richard J B Dobson,Naomi R Wray,Frederik J Steyn,Ammar Al-Chalabi
DOI: https://doi.org/10.1016/j.celrep.2020.108323
2020-10-27
Abstract:We meta-analyze amyotrophic lateral sclerosis (ALS) genome-wide association study (GWAS) data of European and Chinese populations (84,694 individuals). We find an additional significant association between rs58854276 spanning ACSL5-ZDHHC6 with ALS (p = 8.3 × 10-9), with replication in an independent Australian cohort (1,502 individuals; p = 0.037). Moreover, B4GALNT1, G2E3-SCFD1, and TRIP11-ATXN3 are identified using a gene-based analysis. ACSL5 has been associated with rapid weight loss, as has another ALS-associated gene, GPX3. Weight loss is frequent in ALS patients and is associated with shorter survival. We investigate the effect of the ACSL5 and GPX3 single-nucleotide polymorphisms (SNPs), using longitudinal body composition and weight data of 77 patients and 77 controls. In patients' fat-free mass, although not significant, we observe an effect in the expected direction (rs58854276: -2.1 ± 1.3 kg/A allele, p = 0.053; rs3828599: -1.0 ± 1.3 kg/A allele, p = 0.22). No effect was observed in controls. Our findings support the increasing interest in lipid metabolism in ALS and link the disease genetics to weight loss in patients.